# Clinical Lymphoma Myeloma & Leukemia

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/clinical-lymphoma-myeloma-and-leukemia/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 2152-2650 |
| ISSNs | 2152-2650,2152-2669 |
| OpenAlex ID | https://openalex.org/S186546955 |
| Publisher | Elsevier BV |

## Journal papers

- [Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment](https://scholariq.org/papers/final-3-year-results-of-the-dasatinib-discontinuation-trial-in-patients-with/)
- [Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma](https://scholariq.org/papers/randomized-clinical-trial-representativeness-and-outcomes-in-real-world-patients/)
- [Beyond the CRAB Symptoms: A Study of Presenting Clinical Manifestations of Multiple Myeloma](https://scholariq.org/papers/beyond-the-crab-symptoms-a-study-of-presenting-clinical-manifestations-of/)
- [Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States](https://scholariq.org/papers/prolonged-duration-of-therapy-is-associated-with-improved-survival-in-patients/)
- [Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature](https://scholariq.org/papers/chimeric-antigen-receptor-t-cell-car-t-cell-therapy-for-primary-and-secondary/)
- [Rituximab Maintenance Therapy Until Progression After Rituximab and Chemotherapy Induction in Patients With Follicular Lymphoma](https://scholariq.org/papers/rituximab-maintenance-therapy-until-progression-after-rituximab-and-chemotherapy/)
- [Daratumumab-induced Choroidal Effusion: A Case Report and Review of the Literature](https://scholariq.org/papers/daratumumab-induced-choroidal-effusion-a-case-report-and-review-of-the/)
- [WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML – A Single-center 14-year Experience](https://scholariq.org/papers/wt1-gene-expression-in-peripheral-blood-before-and-after-allogeneic-stem-cell/)
- [P-244 Teclistamab versus Belgian real-world clinical practice in triple-class exposed relapsed and refractory multiple myeloma patients using adjusted comparison](https://scholariq.org/papers/p-244-teclistamab-versus-belgian-real-world-clinical-practice-in-triple-class/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.